Taken together with the results from the preventative setting, these studies collectively indicate that CD4+ T cells play a role in vessel maturation early in tumor development while ICIs act through CD8+ T cells to normalize blood vessels in the treatment setting. The gene discussed is CD8A; the disease is neoplasm.